Lancet Microbe

Scope & Guideline

Connecting Science and Solutions in Microbiology

Introduction

Welcome to the Lancet Microbe information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Lancet Microbe, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN-
PublisherELSEVIER
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationLANCET MICROBE / Lancet Microbe
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

Lancet Microbe focuses on advancing the understanding of infectious diseases, their epidemiology, and the development of innovative diagnostics and therapeutics. The journal emphasizes the integration of genomic data and microbiome studies to address public health challenges related to microbial infections and antimicrobial resistance.
  1. Infectious Disease Epidemiology:
    The journal publishes research that investigates the patterns, causes, and effects of infectious diseases in populations, utilizing statistical models and epidemiological frameworks.
  2. Microbial Genomics:
    There is a significant focus on genomic studies that explore the genetic basis of pathogen virulence, antibiotic resistance, and the evolution of microbial populations.
  3. Antimicrobial Resistance (AMR) Studies:
    Lancet Microbe places a strong emphasis on research related to the emergence and spread of antimicrobial resistance, including surveillance studies and the development of novel therapeutic strategies.
  4. One Health Approach:
    The journal promotes interdisciplinary research that connects human, animal, and environmental health, highlighting the interconnectedness of infectious disease dynamics.
  5. Innovative Diagnostic Techniques:
    Research on new diagnostic methods, including molecular and genomic techniques, is a core area, aiming to improve the detection and management of infectious diseases.
  6. Clinical Trials and Therapeutics:
    The journal features studies assessing the efficacy and safety of vaccines and therapeutics for various infectious diseases, particularly in response to emerging health threats.
Recent publications in Lancet Microbe indicate several emerging themes that reflect current trends in infectious disease research, particularly in response to global health challenges.
  1. COVID-19 Research:
    Research related to COVID-19 remains a dominant theme, with a focus on vaccine efficacy, long-term effects, and the dynamics of variants, as the pandemic continues to influence public health priorities.
  2. Microbiome Studies:
    There is a growing interest in the role of the microbiome in health and disease, particularly its interaction with infectious agents and its impact on treatment outcomes.
  3. Zoonotic Disease Surveillance:
    Studies addressing zoonotic diseases, particularly in the context of environmental changes and human-animal interactions, are increasingly prevalent, reflecting concerns over emerging infectious diseases.
  4. Antimicrobial Stewardship Programs:
    Research focused on strategies for optimizing antimicrobial use and combating resistance through stewardship initiatives is gaining traction, highlighting the need for responsible antibiotic usage.
  5. Global Health Equity and Access to Care:
    Emerging themes emphasize the importance of equitable access to healthcare and vaccines, particularly in low- and middle-income countries, as part of a comprehensive response to infectious diseases.

Declining or Waning

While Lancet Microbe has consistently focused on certain core areas, some themes appear to be declining in prominence based on recent publications. This shift may reflect changing research priorities or emerging public health needs.
  1. Traditional Antibiotic Development:
    Research specifically focused on traditional antibiotic development seems to be waning, possibly due to a growing emphasis on alternative therapies and the need for more innovative approaches to combat antibiotic resistance.
  2. Single Pathogen Studies:
    There is a noticeable decline in studies focusing solely on individual pathogens without considering broader microbial interactions or community dynamics, indicating a shift towards more holistic approaches.
  3. Non-Genomic Surveillance Techniques:
    As genomic technologies and molecular techniques gain prominence, traditional surveillance methods that do not incorporate genomic data are becoming less frequently reported in the literature.
  4. In-depth Studies on Established Vaccines:
    Research centered on well-established vaccines is less prevalent, as there is a greater focus on novel vaccine development and the response to emerging pathogens.

Similar Journals

Microbiology Spectrum

Empowering discoveries in microbiology and beyond.
Publisher: AMER SOC MICROBIOLOGYISSN: 2165-0497Frequency: 6 issues/year

Microbiology Spectrum is a prominent peer-reviewed journal published by the American Society for Microbiology, dedicated to advancing the field of microbiology through the dissemination of high-quality research. Since its inception in 2013 and continuing until 2024, the journal has established a strong presence in key domains such as microbiology, immunology, cell biology, and ecology, achieving impressive quartile rankings including Q1 in Infectious Diseases and Q1 in Immunology and Microbiology as of 2023. With an emphasis on open access to its scholarly content, Microbiology Spectrum aims to foster collaboration and knowledge sharing among researchers, professionals, and students alike. The journal's scope encompasses a diverse range of topics pertinent to the field, making it an essential resource for anyone involved in microbiological research and its applications. Researchers looking to publish their findings in a respected journal will find Microbiology Spectrum's robust impact factor and Scopus rankings serve as testament to its significance and influence within the academic community.

ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY

Unveiling the Complexities of Microbial Interactions
Publisher: SPRINGERISSN: 0003-6072Frequency: 12 issues/year

ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY, published by Springer, is a vital resource for advancing research in the fields of microbiology and molecular biology. With its ISSN 0003-6072 and E-ISSN 1572-9699, this journal consistently focuses on cutting-edge studies and developments, providing a platform for the dissemination of knowledge that spans over its rich history from 1934 onwards. The journal holds an impressive reputation, ranked Q2 in Medicine (miscellaneous) and Q3 in both Microbiology and Molecular Biology for 2023, reflecting its significant contribution to the scientific community. Researchers and professionals from various disciplines rely on this journal for quality publications that address complex microbial interactions and molecular mechanisms. Although it currently does not provide open access options, its compelling research remains accessible through institutional subscriptions, allowing it to foster collaborative advancements in the ever-evolving landscape of microbiological sciences.

Mediterranean Journal of Infection Microbes and Antimicrobials

Innovating solutions for a healthier tomorrow.
Publisher: GALENOS PUBL HOUSEISSN: 2147-673XFrequency: 1 issue/year

Mediterranean Journal of Infection Microbes and Antimicrobials is a distinguished open-access journal published by GALENOS PUBL HOUSE, dedicated to advancing the understanding of infectious diseases and microbiology. Since its inception in 2011, this journal has been a vital resource for researchers, professionals, and students interested in the intricate world of microbes and their impacts on human health. With its ISSN 2147-673X, the journal has progressively gained visibility, although it currently holds a Q4 ranking in multiple categories including Immunology and Microbiology, and Infectious Diseases for the year 2023. The journal operates from its headquarters in Istanbul, Turkey, and features a rich array of articles that contribute to the field’s body of knowledge. As a platform enhancing the accessibility of research, it invites submissions from global contributors to foster collaboration and innovation in tackling microbial challenges.

International Journal of Microbiology

Transforming Microbiology Research into Global Impact
Publisher: HINDAWI LTDISSN: 1687-918XFrequency: 1 issue/year

Welcome to the International Journal of Microbiology, a premier platform dedicated to the dissemination of cutting-edge research in the field of microbiology. Published by HINDAWI LTD, this open-access journal has been making significant strides since its inception in 2009, ensuring that high-quality research is accessible to all. Situated in Egypt, the journal caters to an international audience, fostering collaboration across borders. With a commendable impact factor and recognized in the Q2 category for both general and medical microbiology, it ranks 48th out of 182 and 40th out of 140, respectively, according to Scopus statistics, placing it among the top-tier journals in its field. The International Journal of Microbiology publishes articles that explore various aspects of microbiology, from fundamental studies to applied research, thus contributing significantly to advancements in medical, agricultural, and environmental microbiology. This journal is an essential resource for researchers, professionals, and students eager to stay at the forefront of microbiological studies and their applications.

INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Transforming Microbiology into Actionable Health Solutions
Publisher: ELSEVIER GMBHISSN: 1438-4221Frequency: 8 issues/year

Welcome to the International Journal of Medical Microbiology, a leading publication in the field of microbiological research and infectious diseases, offered by Elsevier GmbH. Established in 2000, this esteemed journal provides a scholarly platform for the presentation of high-quality research, reviews, and innovations that bridge medical microbiology and clinical applications. With an impressive impact factor positioning it within the Q1 category across multiple disciplines, including Infectious Diseases, Microbiology, and Medicine, the journal is recognized for its rigorous peer-review process and significant contributions to advancing our understanding of microbial pathogenesis, diagnostics, and therapeutics. The International Journal of Medical Microbiology is committed to open access, promoting the dissemination of knowledge and accessibility for researchers, professionals, and students worldwide. Based in Munich, Germany, the journal continues to play a vital role in the global scientific community, fostering collaborations and inspiring future innovations in the fight against infectious diseases.

New Microbes and New Infections

Innovating solutions for a healthier tomorrow through microbial research.
Publisher: ELSEVIER SCI LTDISSN: Frequency: 6 issues/year

New Microbes and New Infections is an esteemed peer-reviewed journal published by Elsevier Sci Ltd that has been a prominent platform for disseminating groundbreaking research in the fields of Infectious Diseases and Microbiology since its establishment in 2013. With an impressive Open Access model, this journal ensures that vital research findings are readily accessible to researchers, healthcare professionals, and academics worldwide. Positioned in the Q2 category for Infectious Diseases and Q3 for Microbiology in 2023, it reaches a significant global audience, as demonstrated by its high Scopus rankings—#44 out of 344 in Medicine: Infectious Diseases, and #34 out of 182 in Immunology and Microbiology. The journal aims to inspire new ideas and foster collaborations by publishing high-quality research focused on novel microbes and infections, thus playing a crucial role in advancing science and public health in an era where understanding infectious agents is more vital than ever.

MIKROBIYOLOJI BULTENI

Pioneering Insights in Immunology and Microbiology
Publisher: ANKARA MICROBIOLOGY SOCISSN: 0374-9096Frequency: 4 issues/year

MIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.

mSphere

Fostering innovation in microbial and molecular sciences.
Publisher: AMER SOC MICROBIOLOGYISSN: Frequency: 6 issues/year

mSphere is a leading open-access journal published by the American Society for Microbiology, dedicated to the dynamic fields of Microbiology and Molecular Biology. Since its inception in 2016, mSphere has rapidly established itself as a reputable source of scholarly research, achieving notable impact factors and excellence within the academic community. The journal ranks in the top quartile (Q1) amongst its peers in Microbiology, and Q2 in the field of Molecular Biology, demonstrating its significance and relevance through Scopus rankings—specifically, it holds the #42 spot out of 182 in the Microbiology category and #108 out of 410 in Molecular Biology. With an editorial commitment to advancing the understanding of microbial and molecular sciences, mSphere provides an accessible platform for researchers, professionals, and students alike to disseminate groundbreaking findings. The journal promotes rigorous peer-review and invites innovative contributions aimed at enhancing microbial research mobility and molecular exploration. Accessible openly since 2016, mSphere continues to thrive as an influential publication driving scientific dialogue and discovery in the microbiological sciences.

Annals of Clinical Microbiology and Antimicrobials

Pioneering discussions that shape the future of healthcare.
Publisher: BMCISSN: Frequency: 1 issue/year

Annals of Clinical Microbiology and Antimicrobials, published by BMC, is a leading open-access journal that has been fostering scientific discourse in the fields of microbiology and infectious diseases since its inception in 2002. With an established reputation for excellence, this journal is positioned in the prestigious Q1 category across multiple disciplines, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology as of 2023. This journal serves as a vital platform for researchers, healthcare professionals, and students, promoting the latest advancements in clinical microbiology and antimicrobial research. Access to its invaluable content is open to all, reflecting the commitment to disseminate knowledge universally. The Annals of Clinical Microbiology and Antimicrobials is based in the United Kingdom and continues to pave the way for innovation and discussions that shape the future of clinical practices in microbiology.

BMC MICROBIOLOGY

Connecting minds through groundbreaking microbiology insights.
Publisher: BMCISSN: 1471-2180Frequency: 1 issue/year

BMC Microbiology is a leading open access journal published by BMC, dedicated to advancing the field of microbiology since its inception in 2001. With an ISSN of 1471-2180, this journal provides a vital platform for researchers, professionals, and students to share and access high-quality research and innovation in both general and medical microbiology. Based in the United Kingdom, BMC Microbiology holds a commendable Q2 ranking in both various microbiological categories according to the 2023 Scopus rankings, indicating its strong influence in the microbiological community, with a rank of #47 out of 140 in Medical Microbiology and #62 out of 182 in general Microbiology. The journal's commitment to open access ensures that groundbreaking research is freely available to facilitate collaboration and knowledge sharing among the global community of microbiologists. With a focus on publishing original research, reviews, and case studies, BMC Microbiology plays a critical role in disseminating information that can impact health and environmental conditions around the world.